Whileno cure or totally effective medication has yet been created, there are anumber of memory loss medications that are FDA approved and on the market atthis time. These medications simply help manage the symptoms and in some casesslow down the rate of progression of the disease. (alzheimers.ie) However, these medications can be unpopularbecause of their unpleasant side effects which can be particularly tough onolder people with the disease.Current medications on the market in the United States of America: Generic name Brand name Approved for Donepezil Aricept All stages Galantamine Razadyne Mild to moderate Revastigmine Exelon Mild to moderate Memantine Namenda Moderate to severe Donepezil + Memantine Namzaric Moderate to severe The first three drugs on this list,Donepezil, Galantamine and Revastigmine are all from a class of drugs which arecalled acetylcholinesterase inhibitor.
Cholinesterase inhibitors are drugs that stop or impedeenzymes from breaking down acetylcholine when it is transported from one cellto another. This means that the acetylcholine, which is in short supply inpeople with Alzheimer’s disease, is not destroyed so quickly and there is morechance of it being passed on to the next nerve cell. Cholinesterase inhibitorsresult in higher concentrations of acetylcholine, leading to increasedcommunication between nerve cells, which in turn, may temporarily improve orstabilise the symptoms of dementia. The use of cholinesterase inhibitors isonly one possible pharmaceutical approach to treating the symptoms ofAlzheimer’s disease. Other neurotransmitters are involved and may also beimportant. (dementia australia, 2006) Bibliography alzheimers.
ie. (n.d.). Treating dementia.
Retrieved from alzheimers.ie: https://www.alzheimer.ie/Living-with-dementia/I-have-Dementia/Treatments.
aspx dementia australia. (2006). Drug treatments for Alzheimer’s disease.
Retrieved from https://www.dementia.org.au/files/helpsheets/Helpsheet-DementiaQandA01-CholinesteraseInhibitors_english.pdf